JB Capital LLC Acquires 137 Shares of The Cigna Group (NYSE:CI)

JB Capital LLC boosted its holdings in shares of The Cigna Group (NYSE:CIFree Report) by 1.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,377 shares of the health services provider’s stock after buying an additional 137 shares during the quarter. JB Capital LLC’s holdings in The Cigna Group were worth $3,248,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Rehmann Capital Advisory Group acquired a new position in The Cigna Group during the 1st quarter worth $268,000. Larson Financial Group LLC lifted its position in shares of The Cigna Group by 198.8% during the 1st quarter. Larson Financial Group LLC now owns 245 shares of the health services provider’s stock worth $89,000 after purchasing an additional 163 shares during the last quarter. CFO4Life Group LLC bought a new stake in The Cigna Group during the 1st quarter valued at approximately $735,000. Empirical Finance LLC grew its holdings in The Cigna Group by 3.2% in the 1st quarter. Empirical Finance LLC now owns 11,155 shares of the health services provider’s stock valued at $4,051,000 after buying an additional 347 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. increased its position in The Cigna Group by 20.2% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 26,921 shares of the health services provider’s stock worth $9,777,000 after buying an additional 4,525 shares during the period. 86.99% of the stock is currently owned by institutional investors.

Insider Activity at The Cigna Group

In related news, Director William J. Delaney III sold 2,691 shares of the business’s stock in a transaction on Monday, August 19th. The shares were sold at an average price of $342.68, for a total transaction of $922,151.88. Following the transaction, the director now directly owns 17,539 shares in the company, valued at approximately $6,010,264.52. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. Cantor Fitzgerald restated an “overweight” rating and issued a $400.00 price objective on shares of The Cigna Group in a research note on Wednesday, October 23rd. JPMorgan Chase & Co. raised their price target on shares of The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 21st. Royal Bank of Canada cut their price objective on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. StockNews.com downgraded The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday. Finally, Piper Sandler restated an “overweight” rating and set a $394.00 price target (up from $392.00) on shares of The Cigna Group in a research note on Tuesday. One investment analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, The Cigna Group has a consensus rating of “Buy” and an average price target of $394.64.

View Our Latest Research Report on The Cigna Group

The Cigna Group Stock Up 1.1 %

The Cigna Group stock traded up $3.32 during midday trading on Thursday, reaching $318.54. The stock had a trading volume of 155,771 shares, compared to its average volume of 1,528,768. The stock has a market capitalization of $88.60 billion, a P/E ratio of 29.73, a price-to-earnings-growth ratio of 0.96 and a beta of 0.51. The firm’s fifty day simple moving average is $343.37 and its 200-day simple moving average is $340.80. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.72 and a current ratio of 0.72. The Cigna Group has a 1-year low of $253.95 and a 1-year high of $370.83.

The Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 EPS for the quarter, topping analysts’ consensus estimates of $7.22 by $0.29. The business had revenue of $63.70 billion for the quarter, compared to analyst estimates of $59.58 billion. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The firm’s revenue for the quarter was up 29.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.77 earnings per share. As a group, analysts expect that The Cigna Group will post 28.48 EPS for the current fiscal year.

The Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Wednesday, December 4th will be given a dividend of $1.40 per share. The ex-dividend date is Wednesday, December 4th. This represents a $5.60 annualized dividend and a yield of 1.76%. The Cigna Group’s dividend payout ratio (DPR) is presently 52.83%.

The Cigna Group Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Further Reading

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.